Ftse Mib
35.376,34
0,03%
DAX
18.867,32
-0,04%
S&P 500
5.308,15
1,17%
NASDAQ
16.742,39
1,40%
Bitcoin
66.244,32
-0,02%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Marizyme Inc (QB) (MRZM) Marizyme Inc (QB) (MRZM) Notizie

MRZM

Marizyme (QB) (MRZM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:MRZM
DataOraFonteTitoloSimboloCompagnia
15/05/202422:05Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:MRZMMarizyme Inc (QB)
13/05/202422:50Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:MRZMMarizyme Inc (QB)
06/05/202423:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:MRZMMarizyme Inc (QB)
06/02/202422:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:MRZMMarizyme Inc (QB)
29/12/202302:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:MRZMMarizyme Inc (QB)
14/11/202322:27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:MRZMMarizyme Inc (QB)
18/10/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:MRZMMarizyme Inc (QB)
08/09/202316:22Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]USOTC:MRZMMarizyme Inc (QB)
31/07/202314:57Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:MRZMMarizyme Inc (QB)
18/07/202322:59Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933USOTC:MRZMMarizyme Inc (QB)
12/07/202322:26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsUSOTC:MRZMMarizyme Inc (QB)
23/06/202322:55Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:MRZMMarizyme Inc (QB)
23/06/202322:53Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:MRZMMarizyme Inc (QB)
05/06/202322:20Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MRZMMarizyme Inc (QB)
02/06/202322:08Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:MRZMMarizyme Inc (QB)
15/05/202322:13Edgar (US Regulatory)Quarterly Report (10-q)USOTC:MRZMMarizyme Inc (QB)
26/04/202323:28Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:MRZMMarizyme Inc (QB)
20/04/202321:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:MRZMMarizyme Inc (QB)
31/03/202312:02Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:MRZMMarizyme Inc (QB)
09/02/202322:46Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:MRZMMarizyme Inc (QB)
01/06/202221:22Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:MRZMMarizyme Inc (QB)
31/03/202223:20Edgar (US Regulatory)Annual Report (10-k)USOTC:MRZMMarizyme Inc (QB)
22/11/202119:26Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:MRZMMarizyme Inc (QB)
15/11/202122:23Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:MRZMMarizyme Inc (QB)
03/11/202111:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:MRZMMarizyme Inc (QB)
05/08/202115:41Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)USOTC:MRZMMarizyme Inc (QB)
31/03/202123:01Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:MRZMMarizyme Inc (QB)
05/08/202015:59Edgar (US Regulatory)Amended Small Company Offering and Sale of Securities Without Registration (d/a)USOTC:MRZMMarizyme Inc (QB)
14/03/201913:14InvestorsHub NewsWireMarizyme, Inc.'s Krillase Therapeutic Platform Shows Wide Medical Application and Treatment Potential -- Spotlight GrowthUSOTC:MRZMMarizyme Inc (QB)
28/11/201822:08Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:MRZMMarizyme Inc (QB)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:MRZM

La tua Cronologia

EU
ULAP
Unibail Rodamco Westfiel...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network